Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Orthopaedics
  • Orthopaedics News
  • Antidepressants may...

Antidepressants may relieve pain in knee osteoarthritis, but with "CAUTION", research suggests

Written By : Aditi |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2022-12-20T11:15:53+05:30  |  Updated On 20 Dec 2022 1:10 PM IST
Antidepressants may relieve pain in knee osteoarthritis, but with CAUTION, research suggests
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Australia: A review published in the Cochrane Database of Systematic Reviews has concluded that antidepressant use in knee osteoarthritis is related to improved pain and function (non‐clinically). The researchers also mentioned a 50% or greater "important improvement" in a small number of people.

It is already known that Osteoarthritis is a painful disease of the joints characterized by deformity and disability. In this joint condition, there is reduced cartilage and narrowing of the space between the joints.

Pain is common in Osteoarthritis, and most patients fail to achieve adequate pain relief. There are many investigations of medications affecting pain processing due to increasing acknowledgement of contribution in pain sensitization.

Antidepressants may play a role in managing pain in Osteoarthritis. These act by modulating nerve pathways that affect pain in the central nervous system.

Considering this, a review was done by a team of researchers led by Dr Leaney from the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. The team evaluated the benefits and harm of antidepressants for knee and hip osteoarthritis pain.

The critical points of the review are:

• The search method used was the standard, extensive Cochrane search method.

• January 2021 was the latest search.

• The review included randomized controlled trials of adults with a history of Osteoarthritis.

• The use of antidepressants was compared to a placebo or alternative comparator.

• Pain, responder rate, physical function, life quality, and withdrawal due to an adverse event was the major outcome.

• The minor outcomes measured in the study were the OARSI (Osteoarthritis Research Society International) Response Criteria, radiographic joint structure changes and dropper proportion of participants.

• The certainty of the evidence was assessed using GRADE.

• The review included nine clinical trials of trial size 36 to 388 participants, seven for knee osteoarthritis and two for hip osteoarthritis.

• The mean age of study participants was 54.5 to 65.9 years, primarily females.

• The duration of the trial was 8 to 16 weeks.

• Duloxetine was examined in six trials.

• The antidepressants resulted in a small benefit as compared to the placebo.

• The pain reduction in the placebo group was 1.73 points.

• The pain reduction in the antidepressant group was 2.32 points.

• The mean improvement in function was 10.51 points with placebo and 16.16 points with antidepressants (clinically unimportant).

• There was more risk of stopping treatment, 2.15 more in the antidepressant group than placebo.

• In placebo, life quality improved by 0.07 points per the EuroQol 5‐Dimension scale.

• The life quality improved by 0.11 points with antidepressants.

• Total adverse events were more in the antidepressant group (64%) than in the placebo group (49%), with an RR of 1.27.

• 11% of participants on antidepressants withdrew from trials compared to 5% on placebo with RR, 2.15 and NNTH, 17.

The researchers said the cause of pain osteoarthritis is due to various causes that vary with different individuals. It may be due to this reason that only a small number of people respond to the therapy.

• As recorded, 28.65% and 45.2 % of people on placebo and antidepressants had a clinical response respectively.

• Physical function improved 6% more with antidepressants than with placebo.

• The improvement in function in the placebo and antidepressant groups was 10.51 and 16.16 points.

Quality of life improved by 4%, with 0.07 points in placebo and 0.11 points in antidepressants.

The researcher wrote the following in conclusion,

We conclude that 1 in 6 patients with painful hip or knee osteoarthritis achieved a 50% or more significant reduction in pain when treated with antidepressants than placebo.

We recorded little difference in serious side effects between antidepressants and placebo. Nearly 5.1 % in the placebo and 10.9 % in the antidepressant group withdrew due to side effects. Antidepressants have more side effects than placebo, so they are likely to be stopped, 64.1 % in antidepressants and 49.3 % in placebo.

The serious side effects in the antidepressant and placebo group were 1.6 % and 1.7 %, they mentioned.

Mentioning the total side effect, they wrote the risk of any side effects is 1.27 more in the antidepressant than in the placebo group. In the antidepressant group, 14.8 % had side effects equivalent to 1 in every 7patient having a side effect.

Further reading:

Leaney AA, Lyttle JR, Segan J, Urquhart DM, Cicuttini FM, Chou L, Wluka AE. Antidepressants for hip and knee osteoarthritis. Cochrane Database Syst Rev. 2022 Oct 21;10(10)

antidepressantsknee osteoarthritiship osteoarthritiscochrane Database of Systematic Reviews
Source : Cochrane Database of Systematic Reviews
Aditi
Aditi

    BDS, MDS in Periodontics and Implantology

    Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    View All

    Journal Club Today

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    View All

    Health News Today

    Health Bulletin 31/May/2025

    Health Bulletin 31/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok